help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 67, No. 3 465-473
doi:10.1210/jcem-67-3-465
Copyright © 1988 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PADMANABHAN, V.
Right arrow Articles by BEITINS, I. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PADMANABHAN, V.
Right arrow Articles by BEITINS, I. Z.

Modulation of Serum Follicle-Stimulating Hormone Bioactivity and Isoform Distribution by Estrogenic Steroids in Normal Women and in Gonadal Dysgenesis*

VASANTHA PADMANABHAN, LAVONNE L. LANG, JOANNE SONSTEIN, ROBERT P. KELCH and INESE Z. BEITINS

Department of Pediatrics, Division of Pediatric Endocrinology, University of Michigan Ann Arbor, Michigan 48109

Address requests for reprints to: Dr. Padmanabhan, D 3252 Medical Professional Building, Department of Pediatrics, University of Michigan Hospitals, Ann Arbor, Michigan 48109-0781.

To determine the influence of estrogenic steroids on serum FSH bioactivity (B) and immunoreactivity (I) and the FSH isoform distribution profiles, we studied normal women during ovulatory menstrual cycles and a patient with gonadal dysgenesis treated with diethylstilbestrol (DES). Four women with ovulatory menstrual cycles, as judged from their serum immunoreactive LH, FSH, progesterone, and estradiol profiles in daily blood samples, had a significant increase in the mean FSH B/I ratio (P < 0.05) during the midcycle phase of their menstrual cycles. Similarly, in the patient with gonadal dysgenesis the FSH B/I ratio rose significantly (P < 0.05) after 3 weeks of DES treatment and declined during the posttreatment period. In five additional normal women, serum obtained during the follicular, midcycle, and luteal phases of their menstrual cycles was chromatofocused, and the FSH isoform distribution pattern determined. Sera obtained from the patient with gonadal dysgenesis before, during, and after DES administration were pooled and studied similarly. Chromatofocusing of a human pituitary tumor extract allowed for determination of the FSH B/I ratio in different pH ranges. The highest FSH B/I ratio was found in the more basic fractions (pH range 5.6–6.0) compared to the acidic fractions. During both the midcycle phase of the normal cycles and the DES administration period in the studies of the patient with gonadal dysgenesis, there was a shift of the FSH isoforms (as measured by immunoassay) to the basic pH range. In contrast, the mid- to late luteal phase samples, which had low B/I ratios, had an increase in FSH isoforms in the acidic pH range (<4.8). Similarly, in the patient with gonadal dysgenesis FSH isoforms in the basic range were more abundant during the DES treatment period than in the pre- or posttreatment serum pools. Therefore, it appears that endogenous and exogenous estrogenic stimulation alters FSH isoform distribution such that FSH isoforms that are more basic and have increased biological activity are secreted.

* Presented in part at the American Physiological Society Meeting, New Orleans, LA, 1986, and the 69th Annual Meeting of The Endocrine Society, Indianapolis, IN, 1987. This work was supported by NIH Grant HD-18515 and biomedical support grants (to V.P. and I.Z.B).

Received February 5, 1988.




This article has been cited by other articles:


Home page
Biol. Reprod.Home page
T. L. Steckler, J. S. Lee, W. Ye, E. K. Inskeep, and V. Padmanabhan
Developmental Programming: Exogenous Gonadotropin Treatment Rescues Ovulatory Function But Does Not Completely Normalize Ovarian Function in Sheep Treated Prenatally with Testosterone
Biol Reprod, October 1, 2008; 79(4): 686 - 695.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Wide, T. Naessen, I. Sundstrom-Poromaa, and K. Eriksson
Sulfonation and Sialylation of Gonadotropins in Women during the Menstrual Cycle, after Menopause, and with Polycystic Ovarian Syndrome and in Men
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4410 - 4417.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Endocr. Rev., April 1, 2006; 27(2): 170 - 207.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E.V. Velasquez, S. Creus, R.V. Trigo, S.B. Cigorraga, E.H. Pellizzari, H.B. Croxatto, and S. Campo
Pituitary-ovarian axis during lactational amenorrhoea. II. Longitudinal assessment of serum FSH polymorphism before and after recovery of menstrual cycles
Hum. Reprod., April 1, 2006; 21(4): 916 - 923.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. Ulloa-Aguirre, C. Timossi, J. Barrios-de-Tomasi, A. Maldonado, and P. Nayudu
Impact of Carbohydrate Heterogeneity in Function of Follicle-Stimulating Hormone: Studies Derived from in Vitro and in Vivo Models
Biol Reprod, August 1, 2003; 69(2): 379 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Perlman, B. van den Hazel, J. Christiansen, S. Gram-Nielsen, C. B. Jeppesen, K. V. Andersen, T. Halkier, S. Okkels, and H. T. Schambye
Glycosylation of an N-Terminal Extension Prolongs the Half-Life and Increases the in Vivo Activity of Follicle Stimulating Hormone
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3227 - 3235.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. S. Golub, C. E. Hogrefe, S. L. Germann, B. L. Lasley, K. Natarajan, and A. F. Tarantal
Effects of Exogenous Estrogenic Agents on Pubertal Growth and Reproductive System Maturation in Female Rhesus Monkeys
Toxicol. Sci., July 1, 2003; 74(1): 103 - 113.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. R. West, N. E. Carlson, J. S. Lee, A. S. McNeilly, T. P. Sharma, W. Ye, and V. Padmanabhan
Acidic Mix of FSH Isoforms Are Better Facilitators of Ovarian Follicular Maturation and E2 Production than the Less Acidic
Endocrinology, January 1, 2002; 143(1): 107 - 116.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Zarinan, A. Olivares, D. Soderlund, J.P. Mendez, and A. Ulloa-Aguirre
Changes in the biological:immunological ratio of basal and GnRH-releasable FSH during the follicular, pre-ovulatory and luteal phases of the human menstrual cycle
Hum. Reprod., August 1, 2001; 16(8): 1611 - 1618.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Ulloa-Aguirre, C. Timossi, and J.P. Mendez
Is there any physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: I. Gondatrophins are synthesized and released in multiple molecular forms. A matter of fact
Hum. Reprod., April 1, 2001; 16(4): 599 - 604.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
C.Y. Andersen, L. Leonardsen, A. Ulloa-Aguirre, J. Barrios-De-Tomasi, K.S. Kristensen, and A.G. Byskov
Effect of different FSH isoforms on cyclic-AMP production by mouse cumulus-oocyte-complexes: a time course study
Mol. Hum. Reprod., February 1, 2001; 7(2): 129 - 135.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Horsman, J.A. Talbot, J.D. McLoughlin, A. Lambert, and W.R. Robertson
A biological, immunological and physico-chemical comparison of the current clinical batches of the recombinant FSH preparations Gonal-F and Puregon
Hum. Reprod., September 1, 2000; 15(9): 1898 - 1902.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
C. Y. Andersen, L. Leonardsen, A. Ulloa-Aguirre, J. Barrios-De-Tomasi, L. Moore, and A.G. Byskov
FSH-induced resumption of meiosis in mouse oocytes: effect of different isoforms
Mol. Hum. Reprod., August 1, 1999; 5(8): 726 - 731.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Raga, F. Bonilla-Musoles, E.M. Casan, and F. Bonilla
Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome
Hum. Reprod., June 1, 1999; 14(6): 1431 - 1434.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. D'Antonio, F. Borrelli, A. Datola, R. Bucci, M. Mascia, P. Polletta, D. Piscitelli, and R. Papoian
Biological characterization of recombinant human follicle stimulating hormone isoforms
Hum. Reprod., May 1, 1999; 14(5): 1160 - 1167.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. C. J. M. Fauser and A. M. van Heusden
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences
Endocr. Rev., February 1, 1997; 18(1): 71 - 106.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society